TY - JOUR
T1 - Dioxin-induced increase in leukotriene B4 biosynthesis through the aryl hydrocarbon receptor and its relevance to hepatotoxicity owing to neutrophil infiltration
AU - Takeda, Tomoki
AU - Komiya, Yukiko
AU - Koga, Takayuki
AU - Ishida, Takumi
AU - Ishii, Yuji
AU - Kikuta, Yasushi
AU - Nakaya, Michio
AU - Kurose, Hitoshi
AU - Yokomizo, Takehiko
AU - Shimizu, Takao
AU - Hiroshi, Uchi
AU - Furue, Masutaka
AU - Yamada, Hideyuki
N1 - Funding Information:
This work was supported by Exploratory Research Grant 24659053 from the Japan Society for the Promotion of Science and by a Research on Food Safety grant (H24-Designated Research-014) from the Ministry of Health, Labour, and Welfare, Japan. The authors declare that they have no conflicts of interest with the contents of this article. Acknowledgments—The Lipidomics Department of the University of Tokyo is funded by ONO Pharmaceutical Co. and Shimadzu Corp
Publisher Copyright:
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.
PY - 2017/6/23
Y1 - 2017/6/23
N2 - Dioxin and related chemicals alter the expression of a number of genes by activating the aryl hydrocarbon receptors (AHR) to produce a variety of disorders including hepatotoxicity. However, it remains largely unknown how these changes in gene expression are linked to toxicity. To address this issue, we initially examined the effect of 2,3,7,8-tetrachrolodibenzo-p-di-oxin (TCDD), a most toxic dioxin, on the hepatic and serum metabolome in male pubertal rats and found that TCDD causes many changes in the level of fatty acids, bile acids, amino acids, and their metabolites. Among these findings was the discovery that TCDD increases the content of leukotriene B4 (LTB4), an inducer of inflammation due to the activation of leukocytes, in the liver of rats and mice. Further analyses suggested that an increase in LTB4 comes from a dual mechanism consisting of an induction of arachidonate lipoxygenase-5, a rate-limiting enzyme in LTB4 synthesis, and the down-regulation of LTC4 synthase, an enzyme that converts LTA4 to LTC4. The above changes required AHR activation, because the same was not observed in AHR knock-out rats. In agreement with LTB4 accumulation, TCDD caused the marked infiltration of neutrophils into the liver. However, deleting LTB4 receptors (BLT1) blocked this effect. A TCDD-produced increase in the mRNA expression of inflammatory markers, including tumor-necrosis factor and hepatic damage, was also suppressed in BLT1-null mice. The above observations focusing on metabolomic changes provide novel evidence that TCDD accumulates LTB4 in the liver by an AHR-dependent induction of LTB4 biosynthesis to cause hepatotoxicity through neutrophil activation.
AB - Dioxin and related chemicals alter the expression of a number of genes by activating the aryl hydrocarbon receptors (AHR) to produce a variety of disorders including hepatotoxicity. However, it remains largely unknown how these changes in gene expression are linked to toxicity. To address this issue, we initially examined the effect of 2,3,7,8-tetrachrolodibenzo-p-di-oxin (TCDD), a most toxic dioxin, on the hepatic and serum metabolome in male pubertal rats and found that TCDD causes many changes in the level of fatty acids, bile acids, amino acids, and their metabolites. Among these findings was the discovery that TCDD increases the content of leukotriene B4 (LTB4), an inducer of inflammation due to the activation of leukocytes, in the liver of rats and mice. Further analyses suggested that an increase in LTB4 comes from a dual mechanism consisting of an induction of arachidonate lipoxygenase-5, a rate-limiting enzyme in LTB4 synthesis, and the down-regulation of LTC4 synthase, an enzyme that converts LTA4 to LTC4. The above changes required AHR activation, because the same was not observed in AHR knock-out rats. In agreement with LTB4 accumulation, TCDD caused the marked infiltration of neutrophils into the liver. However, deleting LTB4 receptors (BLT1) blocked this effect. A TCDD-produced increase in the mRNA expression of inflammatory markers, including tumor-necrosis factor and hepatic damage, was also suppressed in BLT1-null mice. The above observations focusing on metabolomic changes provide novel evidence that TCDD accumulates LTB4 in the liver by an AHR-dependent induction of LTB4 biosynthesis to cause hepatotoxicity through neutrophil activation.
UR - http://www.scopus.com/inward/record.url?scp=85021625710&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85021625710&partnerID=8YFLogxK
U2 - 10.1074/jbc.M116.764332
DO - 10.1074/jbc.M116.764332
M3 - Article
C2 - 28487374
AN - SCOPUS:85021625710
SN - 0021-9258
VL - 292
SP - 10586
EP - 10599
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 25
ER -